Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-21 Purchase |
2024-11-25 06:03 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $12.91 | $12,910 | 264,148 (Direct) |
View |
| 2024-08-12 Purchase |
2024-09-16 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
800 | $13.85 | $11,080 | 263,148 (Direct) |
View |
| 2024-08-02 Purchase |
2024-08-05 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $15.15 | $15,150 | 262,348 (Direct) |
View |
| 2024-07-18 Purchase |
2024-07-22 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $16 | $16,000 | 261,348 (Direct) |
View |
| 2023-10-27 Purchase |
2023-10-31 06:16 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $8.57 | $4,285 | 260,348 (Direct) |
View |
| 2023-09-26 Purchase |
2023-09-28 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
600 | $8.71 | $5,226 | 259,848 (Direct) |
View |
| 2023-07-13 Purchase |
2023-07-17 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $9.49 | $2,373 | 259,248 (Direct) |
View |
| 2023-04-28 Purchase |
2023-05-02 06:06 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $11.22 | $2,805 | 258,998 (Direct) |
View |
| 2023-04-11 Purchase |
2023-04-12 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
1,000 | $11.87 | $11,870 | 258,745 (Direct) |
View |
| 2023-03-15 Purchase |
2023-03-16 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $12.71 | $3,178 | 257,745 (Direct) |
View |
| 2023-02-24 Purchase |
2023-02-28 06:03 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $15.39 | $3,849 | 257,495 (Direct) |
View |
| 2023-02-03 Purchase |
2023-02-07 06:10 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $20.84 | $5,210 | 257,245 (Direct) |
View |
| 2023-01-27 Purchase |
2023-01-30 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $19.2 | $4,800 | 256,995 (Direct) |
View |
| 2023-01-13 Purchase |
2023-01-17 06:02 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $16.5 | $4,125 | 256,745 (Direct) |
View |
| 2022-12-16 Purchase |
2022-12-20 06:05 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $12.94 | $3,235 | 256,495 (Direct) |
View |
| 2022-12-02 Purchase |
2022-12-06 06:15 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
250 | $13.98 | $3,495 | 256,245 (Direct) |
View |
| 2022-04-19 Purchase |
2022-04-20 06:02 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $16.74 | $8,370 | 255,995 (Direct) |
View |
| 2022-01-31 Purchase |
2022-02-01 06:01 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $18.47 | $9,235 | 255,495 (Direct) |
View |
| 2022-01-21 Purchase |
2022-01-24 06:08 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
500 | $16.33 | $8,165 | 254,995 (Direct) |
View |
| 2022-01-18 Purchase |
2022-01-19 06:09 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg. Affairs |
500 | $18.87 | $9,435 | 254,495 (Direct) |
View |
| 2022-01-13 Purchase |
2022-01-14 06:06 am |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg. Affairs |
1,000 | $19.99 | $19,990 | 253,995 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-24 Option Award |
2024-12-27 4:19 pm |
N/A 2034-12-24 |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
149,818 | $0 | 299,636 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 08:14 am |
N/A 2032-06-22 |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs |
149,818 | $0 | 149,818 (Direct) |
View |
Ownership |
2022-01-11 06:05 am |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical & Reg. Affairs |
0 | $0 | 252,995 (Direct) |
View |
Ownership(A) |
2020-09-30 9:02 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical & Reg Affairs |
0 | $0 | 252,810 (Direct) |
View |
Ownership |
2020-09-24 6:49 pm |
N/A N/A |
Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VPC AND REGULATORY AFFAIRS |
0 | $0 | 140,450 (Direct) |
View |